Salute e Benessere

3Shape Charts Sustainable Course with Release of Comprehensive Sustainability…

The report details 3Shape's sustainability strategy, steps taken so far, and achievements to date in areas such as climate action, pollution, diversity and inclusion, employee wellbeing, responsibility towards consumers and end-users, governance, and integrity. The report details 3Shape's sustainability strategy, steps taken so far, and achievements to date in areas such as climate action, pollution, diversity and inclusion, employee wellbeing, responsibility towards consumers and end-users,...
PR Newswire
10/04/2024

CAMH develops first ever clinically validated natural supplement to prevent…

Up to 8 out of ten new mothers experience postpartum, or 'baby,' blues, characterized by mood swings, crying spells, anxiety and difficulty sleeping. The condition usually begins within the first few days after delivery and may last for up to two weeks. Postpartum blues strongly raises the risk of postpartum depression, a serious mental illness affecting 13 per cent of mothers. Postpartum depression has important health care consequences: impairing quality of life, increasing risk for future…
PR Newswire
10/04/2024

Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare…

Dr. Andrea Maggioni, Director of Global Health at Nicklaus Children's Hospital, expressed deep satisfaction in the hospital's accreditation milestone, remarking, "Achieving a recognition of "Excellence in Medical Travel Services" by Global Healthcare Accreditation underscores our longstanding commitment to pediatric care and affirms our dedication to meeting the highest standards of quality and safety for traveling patients. We are immensely proud of our Global Health team's…
PR Newswire
10/04/2024

MGI Tech Crowned in GHP's Biotechnology Awards 2024 as the Most Innovative…

Global Health & Pharma Magazine (GHP) serves as a vital information hub for the healthcare and pharmaceutical industries. With a global circulation of 110,000, the UK based magazine holds deep respect for the groundbreaking research and intellect within the biotechnology sector. The annual Biotechnology Awards recognize companies at the forefront of innovation, driving progress in biotechnology. Global Health & Pharma Magazine (GHP) serves as a vital information hub for the healthcare…
PR Newswire
10/04/2024

ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in…

ACROBiosystems has successfully developed a multitude of organoids, including cardiac, cerebral, intestinal, liver organoids, along with toxicological evaluation models and disease models for Parkinson's, Alzheimer's, and inflammatory bowel disease. By leveraging its proprietary organoid research and development platform, the company is seeking to continuously expand its solutions by creating organoids like retina, skin, and lung; thereby broadening the scope of organoid applications. Through…
PR Newswire
10/04/2024

Readly joins the National Pharmacy Association's Your Health Your Pharmacy…

The campaign will reach over 3.4 million consumers in its first year with the goal of enhancing public health and reducing pressure on the National Health Service (NHS). Readly will contribute to the dissemination of health and wellness information through free access to its digital magazine and newspaper platform where health conscious consumers can read all the latest news, features and health and wellbeing tips from the 7,700 titles on the app. The campaign will reach over 3.4 million...
PR Newswire
10/04/2024

Gedeon Richter: Cariprazine has a real chance of becoming the best-selling…

Dr. István Greiner, Director of Richter's R&D recounted the story of cariprazine's development. "It was not a one-off success; we have already brought 9 original medicines to the market since World War II. From 1998, we started to focus on the brain's dopamine 3 receptor, and the efforts eventually resulted in cariprazine. It was approved by FDA in 2015 for schizophrenia – first in the history of the Hungarian pharmaceutical industry – later in the EU, and its indications extended in…
PR Newswire
10/04/2024

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

During in-depth discussions with numerous professionals and exhibitors, they were impressed by the leading positions of Tsingke in the fields of oligo synthesis and gene synthesis services, and most of them expressed a strong interest in collaboration. During in-depth discussions with numerous professionals and exhibitors, they were impressed by the leading positions of Tsingke in the fields of oligo synthesis and gene synthesis services, and most of them expressed a strong interest in…
PR Newswire
10/04/2024

"Maxima Grupė" in 2023: 13% Revenue Growth, Focus on Low Prices, and Expansion…

Retail leader in the Baltic States MAXIMA GRUPĖ, UAB, which manages "Maxima" retail chains in Lithuania, Latvia, and Estonia, "Stokrotka" in Poland, "T-Market" in Bulgaria, and the online store "Barbora" in the Baltic States, announces consolidated financial results for 2023. Despite the volatile economic situation in all MAXIMA GRUPĖ's operating markets, the Group managed to maintain financial stability in 2023. Amid high inflation, the Group consistently…
Nasdaq GlobeNewswire
10/04/2024

Philips Respironics reaches agreement with US government on a consent decree…

Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips' subsidiaries Philips Holding USA and Philips Respironics have now reached final agreement on the consent decree with the DOJ and FDA. As previously stated:The consent decree primarily focuses on Philips Respironics' business operations in the US.It provides clarity and a roadmap to demonstrate compliance with regulatory requirements and to...
Nasdaq GlobeNewswire
10/04/2024

Roche obtains CE Mark for first companion diagnostic to identify patients with…

"We are proud to continue our innovation in breast cancer diagnostics through critical tests like this one, which helps identify patients with HER2-low status," said Jill German, Head of Pathology Lab at Roche Diagnostics. "With this expanded approval of our test, we're pleased that more metastatic breast cancer patients across the world may be correctly identified and potentially eligible for this targeted therapy." "We are proud to continue our innovation in breast…
PR Newswire
10/04/2024

R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled…

Respiratory syncytial virus (RSV) is one of the most common viral pathogens that cause acute respiratory infections in infants. In recent years, due to the persistently high incidence of various respiratory diseases, inhalation preparations have seen a growing market demand, especially when used in treating RSV-associated lower respiratory infections in children, thus aerosol inhalation has become a more ideal route of administration. Respiratory syncytial virus (RSV) is one of the most…
PR Newswire
10/04/2024

Taurine Market Projected to Reach $717.98 million by 2030 - Exclusive Report by…

"Taurine Market Flourishes Globally: Driven by Health-Conscious Consumers and Diverse Applications" "Taurine Market Flourishes Globally: Driven by Health-Conscious Consumers and Diverse Applications" The global market for taurine, a sulfur-rich amino acid pivotal in various physiological functions, is experiencing notable growth due to its escalating incorporation into food & beverages, pharmaceuticals, pet food, and cosmetics. The surge in demand for functional foods…
PR Newswire
10/04/2024

Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by…

Key Takeaways from the Tissue Banking Market Report Key Takeaways from the Tissue Banking Market Report To read more about the latest highlights related to the tissue banking market, get a snapshot of the key highlights entailed in theGlobal Tissue Banking Market Report Tissue Banking Overview Tissue banking plays a pivotal role at the intersection of medical research, regenerative medicine, and patient care. These specialized facilities serve as custodians of a diverse...
PR Newswire
09/04/2024

Corneal Edema Therapeutics Market to Grow Significantly at a CAGR of 8.54% in…

Key Takeaways from the Corneal Edema Market Report Discover which therapies are expected to grab the major corneal edema market share @Corneal Edema Market Report Corneal Edema Overview Corneal edema occurs when the cornea, the clear, dome-shaped outer layer of the eye that protects the iris and pupil, swells. This swelling affects the cornea's ability to properly direct light onto the retina for clear vision. The condition results from an excessive buildup of fluid...
PR Newswire
09/04/2024

Ultimovacs – Invitation to Business Update on April 17, 2024

NON-REGULATORY PRESS RELEASEOslo, April 9, 2024:Ultimovacs ASA ("Ultimovacs") (OSE ULTI), Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the company will host a webcast on April 17, 2024, at 11:00. Ultimovacs' management will provide a company update emphasizing recent developments and the future potential within the clinical program. The presentation will be followed by a Q&A...
Nasdaq GlobeNewswire
09/04/2024

EUROAPI streamlines its Executive Committee to improve focus and efficiency

Press Release Paris – April 9, 2024– EUROAPI today announces a streamlining of its Executive Committee around operational functions in order to improve focus and efficiency. This organizational adjustment is part of the transformation of EUROAPI into an innovative API supplier and CDMO with a unique, high-quality and customized product offering. As part of this move, Guillaume Rosso has been appointed as Chief Commercial Officer, succeeding Laurent Alexandre who has...
Nasdaq GlobeNewswire
09/04/2024

Monthly information related to total number of voting rights and shares…

Article 223-16 of general regulation of French Autorité des Marchés FinanciersListing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)Website : www.phaxiam.com DateTotal of shares composing the share capitalTotal of brut(1)voting rightsTotal of net(2)voting rights December 31, 20236 075 1056 226 9826 226 733January 31, 20246 075 1056 227 0026 226 753February 29, 20246 075 1056...
Nasdaq GlobeNewswire
09/04/2024

DUANE LAWRENCE APPOINTED AS CHAIR OF THE ONETOUCH HEALTH GROUP BOARD

Duane believes strongly in dedicating time to organisations and causes that empower individuals to achieve their fullest potential. Currently Duane also serves as a Trustee of the Consortium for Street Children, a global non-governmental organisation committed to fighting for the rights of homeless children worldwide. Duane believes strongly in dedicating time to organisations and causes that empower individuals to achieve their fullest potential. Currently Duane also serves as a Trustee of…
PR Newswire
09/04/2024

Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting

Press ReleaseNicox: 2024 Ordinary and Extraordinary Shareholder MeetingApril 9, 2024 – release at 17:30 CETSophia Antipolis, France Nicox SA(Euronext Paris: FR0013018124, ALCOX), an international ophthalmology company, informs its shareholders that the Ordinary and Extraordinary general meeting convened on first call on Wednesday April 10, 2024, will not be held as the quorum required by law has not been reached.The shareholders of Nicox are thus convened on second call...
Nasdaq GlobeNewswire
09/04/2024

Neoss Integrate Australia 2024 - Integrate. Educate. Celebrate

"This will be the event of the year, not only regarding the educational program that is being presented, but to see the Neoss community come together - I´m looking forward to connecting with both fresh faces and the familiar ones from the early days of Neoss."Prof. Neil Meredith, Co-Founder of Neoss Group. "This will be the event of the year, not only regarding the educational program that is being presented, but to see the Neoss community come together -I´m looking forward to…
PR Newswire
09/04/2024

Clinical Communication & Collaboration Market Worth $4.8 billion |…

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118830286 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118830286 Browse in-depth TOC on "Clinical Communication & Collaboration Market" 240 - Tables 50 - Figures 320 - Pages Clinical Communication & Collaboration Market Scope: Software segment accounted for the largest share of the global Clinical Communication and...
PR Newswire
09/04/2024

Rett syndrome - Market Outlook, Epidemiology, Competitive Landscape, and Market…

Although the disorder is rare, it causes life-long impairment and severe symptoms requiring treatments such as antiepileptics and supportive therapies. Only one drug is USFDA approved for the treatment of RTT: Daybue (trofinetide), which is marketed by Acadia Pharmaceuticals. The drug could help in improving communication, interaction and multiple other features of RTT. However, it cannot cure the condition and opportunities remain for drug development for managing the condition. Although the...
PR Newswire
09/04/2024

MYONEX ANNOUNCES ACQUISITION OF SAVEWAY COMPOUNDING PHARMACY TO EXPAND ITS…

"SaveWay's pharmacy capabilities complement and extend Myonex's existing clinical supplies solutions within the US. SaveWay will provide additional access for drug sourcing and direct-to-patient options across all 50 states for our clinical packaging and labelling and ancillary supply services. SaveWay complements Myonex's market-leading CTRx™ to ensure a full suite of prescription-based supply options for both investigational medicinal product (IMP) and commercial drug access throughout…
PR Newswire
09/04/2024
Altri  Comunicati